Mid-term syllabus of Biochem-403: Introduction to Biosafety, Laboratory hazards, Biosafety levels of research laboratories, Good laboratory practices, International rules & regulations for Biosafety, GMOs handling, Laboratory acquired infections and their transmission routs, Bio waste disposal,
Final exam Biochem-403: Introduction to bioethics, GMOs related ethics, Ethical issues related to reproductive & cloning technologies, Role of institutional bioethical committees.
Start preparing your presentations and assignments….. The presentations will be started right after the mid-term exam.
NO EXCUSE WILL BE ACCEPTED
__________________________________________________________________________________
Objective questions will be from the lectures, manuals, and books uploaded on this web-page.
__________________________________________________________________________________
Assignments and presentations:
- The weightage of the assignment and presentation will be decided later.
- Start preparing your presentations and assignments.
- The presentations will also be started right after the mid-term exam.
- PPT file should not contain any designing/colours other than figures and diagrams.
- Slides should be in 16X9 ratio.
- Fonts of all header should be same and of all other text should be same.
- For detailed guidelines about the presentation of research article, visit: https://www.lifesciencesorg.combiochem-720/
- Download the template ppt file to make your presentation. The link is here (copy this link and paste in a new tab).
- Strictly follow the ppt format and it is better if you write and paste your material in the same ppt file.
K. General Question to be asked during the presentation
- 1) Pathway or importance of gene/technology/discovery
- 2) Rationale
- 3) Conclusion of the full article
- 4) Conclusion of every figure
- 5) New findings presented in the article
- 6) Applications of the findings
- 7) Future prospective
- 8) Applications of the work
- 9) Principle of every technique used in the research article
Moreover, provide me a printed summary of your article containing the above headings given under ‘K’.
L. During Presentations, for EVERY FIGURE and graph, we may ask:
1. The Principle of the experiment.
2. The Reason for doing the experiment/s.
3. The Physiological importance of the figure.
4. The Conclusions of the figure
5. Prepare well objectively and subjectively
______________________________________________________________________________
Microsoft teams will be used whenever online classes will be held. You must make your first name as your registration number.
2017-ag-9382 Haidar Iftikhar
2017-ag-10077 Ahmad Faraz
______________________________________________________________________________
Microsoft Teams link for classes is given below:
https://teams.microsoft.com/l/meetup-join/19:[email protected]/1662975049970?context=%7B%22Tid%22:%2275df096c-8b72-48e4-9b91-cbf79d87ee3a%22,%22Oid%22:%22c066ef7d-a967-4f2e-b3ad-08e007c9866c%22%7D
BIOCHEM-403 BIOSAFETY AND ETHICS 3(3-0)
Objectives
- Introduce the biosafety regulations and ethical concepts in research
- Emphasize on intellectual property rights issues and need for knowledge in patents.
- Apply the concepts of biosafety and better communicate risk management to the public
Theory
Introduction to Biosafety, Laboratory hazards, Biosafety levels of research laboratories, Good laboratory practices, International rules & regulations for Biosafety, GMOs handling, Laboratory acquired infections and their transmission routs, Bio waste disposal, Introduction to bioethics, GMOs related ethics, Ethical issues related to reproductive & cloning technologies, Role of institutional bioethical committees.
Suggested Readings
- Dawn P. Wooley, Karen B. Byers. Biological Safety: Principles and Practices, 5th Edition.2017. ASM Press.
- Department of Health and Human Services. Biosafety in Microbiological and Biomedical Laboratories. 5th Edition.2016. LULU Press.
- Goel and Parashar. IPR Biosafety and Bioethics. Kindle Edition.2013. Pearson Education.
- Bioethics & Biosafety in Biotechnology by V Sree Krishna. 2011.New Age International Limited Publishers
- Laboratory Biosafety manual 3rd edition. WHO. 2006. AITBS publishers and distributors, India.
Biochem-403, BS Biochem, 3rd, M-Winter 2023, Dr. Muhammad Ali; 28-08-2023 | ||||
Sr. | Ag No. | Student’s Name | Group | Research article for presentation and 1 page summary |
1 | 2022-ag-5240 | TAFSEELA AMJAD | G1 | A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors |
2 | 2022-ag-5241 | ALISHA | ||
3 | 2022-ag-5242 | ANSA BIBI | ||
4 | 2022-ag-5243 | HADIA UMAR | ||
5 | 2022-ag-5244 | MARYAM KHALIL | ||
6 | 2022-ag-5245 | AHMAD HASSAN TARIQ | ||
7 | 2022-ag-5246 | ESHA ARSHAD | ||
8 | 2022-ag-5247 | Asma Nasir | ||
9 | 2022-ag-5248 | FARIA NAWAZ | ||
10 | 2022-ag-5249 | ESHA TAHIR | ||
11 | 2022-ag-5251 | SHAFA SAJJAD | G2 | Preclinical evaluation of a novel antibody-drug conjugate targeting DR5 for lymphoblastic leukemia therapy |
12 | 2022-ag-5252 | QIRAT RAZZAQ | ||
13 | 2022-ag-5253 | KASHAF ALAM | ||
14 | 2022-ag-5254 | AISHA ALI | ||
15 | 2022-ag-5255 | ZAINAB | ||
16 | 2022-ag-5256 | BUSHRA NOOR | ||
17 | 2022-ag-5257 | MARIYAM | ||
18 | 2022-ag-5258 | IQRA BATOOL | ||
19 | 2022-ag-5259 | MANAHIL YOUNIS | ||
20 | 2022-ag-5260 | KHUZAIMA NADEEM | G3 | A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors |
21 | 2022-ag-5261 | AYESHA NAVEED | ||
22 | 2022-ag-5262 | FIZA FATIMA | ||
23 | 2022-ag-5263 | VANEEZA AHMAD | ||
24 | 2022-ag-5264 | HAFSA TAHIRA | ||
25 | 2022-ag-5265 | MUHAMMAD MUZAMMAL IKRAM | ||
26 | 2022-ag-5266 | MUHAMMAD BILAL | ||
27 | 2022-ag-5267 | ABDUL HANNAN | ||
28 | 2022-ag-5268 | FAIZA LARAIB | G5 | Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1 |
29 | 2022-ag-5269 | SAHER FARAZ | ||
30 | 2022-ag-5270 | MUHAMMAD USMAN | ||
31 | 2022-ag-5271 | MANAHIL MALIK | ||
32 | 2022-ag-5272 | MAHEEN ASIF CHAUDHARY | ||
33 | 2022-ag-5273 | ZAINAB | ||
34 | 2022-ag-5274 | MUNIM ALI | ||
35 | 2022-ag-5276 | MUBASHAR ALI | ||
36 | 2022-ag-5277 | MUHAMMAD SHAHBAZ JAMIL | G5 | Mesoporous Silica Nanoparticles as Drug Delivery Systems for Targeted Inhibition of Notch Signaling in Cancer |
37 | 2022-ag-5278 | KISA FATIMA | ||
38 | 2022-ag-5279 | MUHAMMAD MOHSIN RAZA | ||
39 | 2022-ag-5280 | KASHAF FATIMA | ||
40 | 2022-ag-5281 | LAIBA AZHAR | ||
41 | 2022-ag-5282 | ANEELA SHAHZADI | ||
42 | 2022-ag-5283 | RABIA RAMZAN | ||
43 | 2022-ag-5284 | EMAN FATIMA | ||
44 | 2022-ag-5285 | MARYAM SADDIQUA | G6 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity |
45 | 2022-ag-5286 | ARIBA AKBAR | ||
46 | 2022-ag-5287 | MARWA NADEEM | ||
47 | 2022-ag-5288 | GHULAM HUSSAIN | ||
48 | 2022-ag-5289 | SAMANIA KHALID | ||
49 | 2022-ag-5292 | LUBABA SAEED | ||
50 | 2022-ag-5293 | NIMRA EMAN | ||
51 | 2022-ag-5294 | RIZA SIKANDAR | ||
52 | 2022-ag-5295 | HAMNA IRSHAD | G7 | BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells |
53 | 2022-ag-5296 | MARYAM HAMDA | ||
54 | 2022-ag-5297 | MARYAM RANI | ||
55 | 2022-ag-5298 | ALI | ||
56 | 2022-ag-5299 | HAIQA AKHTAR | ||
57 | 2022-ag-5300 | SANAA ABBAS | ||
58 | 2022-ag-5301 | ABDUL REHMAN | ||
59 | 2022-ag-5302 | AIMAN HAMID | ||
60 | 2022-ag-5303 | MARIAM FATIMA | ||
61 | 2022-ag-5304 | MALAIKA NADEEM | G8 | The topoisomerase inhibitor CPT-11 prevents the growth and metastasis of lung cancer cells in nude mice by inhibiting EGFR/ MAPK signaling pathway |
62 | 2022-ag-5305 | MAMOONA | ||
63 | 2022-ag-5306 | SABA JAVED | ||
64 | 2022-ag-5307 | MARRIAM SALEEM | ||
65 | 2022-ag-5308 | AFSHEEN QADRI | ||
66 | 2022-ag-5309 | ITRAT FATIMA | ||
67 | 2022-ag-5311 | MAHA | ||
68 | 2022-ag-5312 | ZEESHAN ALI SHAHZAD | ||
69 | 2022-ag-5313 | FARWA ASGHAR | ||
70 | 2022-ag-5314 | UMER AKMAL | G9 | Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model |
71 | 2022-ag-5315 | TAYYABA EMAN | ||
72 | 2022-ag-5316 | DANIYA PAKEEZA | ||
73 | 2022-ag-5317 | TAYBA ALI HUSSAIN | ||
74 | 2022-ag-5318 | AIMAN SHABBIR | ||
75 | 2022-ag-5319 | TAYYABA NAVEED | ||
76 | 2021-ag-7031 | AYESHA ASLAM | ||
77 | 2022-ag-5320 | Fatima Idrees | ||
78 | 2022-ag-5337 | ZAINAB | G10 | ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression |
79 | 2022-ag-5338 | Aliza Ahmad | ||
81 | 2022-ag-5340 | Noor Bhari | ||
82 | 2022-ag-5354 | Hira Fatima | ||
83 | 2022-ag-5355 | Ifra Muzaffar | ||
84 | 2022-ag-5361 | Tayyavba shaukat | ||
85 | 2022-ag-5364 | Fatima Miraj | ||
86 | 2022-ag-5365 | Sabahat Masood |
Biosafety Manual
https://www.unr.edu/ehs/policies-manuals/biosafety-manual
- Purpose, Scope, and Responsibilities
- Approval of Research Projects
- Biosafety Regulations and Guidelines
- Biosafety Principles
- Laboratory Biosafety Practices
- Laboratory Training
- Decontamination
- Laboratory Ventilation for Biosafety
- Human Tissue and Cell Culture
- Work with Biological Toxins
- Incident Response
- Incident Reporting
- Biohazardous Waste
- CDC/USDA Select Agents
- Animal Care and Use in University Research, Testing, and Education Programs
- Packaging and Shipping Infectious Agents
Comments are closed.